chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Immunisation reaction
Clinical narrative: after the first dose she had body aches; fatigue; fever; through up for two day; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (after the first dose she had body aches), FATIGUE (fatigue), PYREXIA (fever) and VOMITING (through up for two day) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21a) for COVID-19 vaccination.     Patient has never been diagnosed/tested positive for Covid-19. Patient did not receive other vaccines within 1 month prior to Moderna COVID-19 vaccine. Patient did not have any acute illnesses or chronic conditions at time of vaccination.  Previously administered products included for Product used for unknown indication: Flu shot (bit more dramatic). Past adverse reactions to the above products included Vaccination adverse reaction with Flu shot. Concurrent medical conditions included Penicillin allergy.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced PAIN (after the first dose she had body aches), FATIGUE (fatigue), PYREXIA (fever) and VOMITING (through up for two day). In 2021, VOMITING (through up for two day) had resolved. At the time of the report, PAIN (after the first dose she had body aches), FATIGUE (fatigue) and PYREXIA (fever) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medication information was provided. Patient did not receive medical care. No treatment medication were provided. The patient stated that she did not got covid, because of the Moderna covid19 vaccine, and everything that happened with her was all broadly publicated online.   This case was linked to MOD-2022-543456, MOD-2022-543457 (Patient Link).
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Fatigue, Throat irritation
Clinical narrative: after the first dose she had body aches; fatigue; fever; through up for two day; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (after the first dose she had body aches), FATIGUE (fatigue), PYREXIA (fever) and VOMITING (through up for two day) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21a) for COVID-19 vaccination.     Patient has never been diagnosed/tested positive for Covid-19. Patient did not receive other vaccines within 1 month prior to Moderna COVID-19 vaccine. Patient did not have any acute illnesses or chronic conditions at time of vaccination.  Previously administered products included for Product used for unknown indication: Flu shot (bit more dramatic). Past adverse reactions to the above products included Vaccination adverse reaction with Flu shot. Concurrent medical conditions included Penicillin allergy.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced PAIN (after the first dose she had body aches), FATIGUE (fatigue), PYREXIA (fever) and VOMITING (through up for two day). In 2021, VOMITING (through up for two day) had resolved. At the time of the report, PAIN (after the first dose she had body aches), FATIGUE (fatigue) and PYREXIA (fever) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medication information was provided. Patient did not receive medical care. No treatment medication were provided. The patient stated that she did not got covid, because of the Moderna covid19 vaccine, and everything that happened with her was all broadly publicated online.   This case was linked to MOD-2022-543456, MOD-2022-543457 (Patient Link).
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Fatigue, Pain, Pyrexia, Vomiting
Clinical narrative: After the second dose, similar but much more mild, lasted for one day, body aches; After the second dose, similar but much more mild, lasted for one day, Fatigue; After the second dose, similar but much more mild, lasted for one day,Fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (After the second dose, similar but much more mild, lasted for one day, body aches), FATIGUE (After the second dose, similar but much more mild, lasted for one day, Fatigue) and PYREXIA (After the second dose, similar but much more mild, lasted for one day,Fever) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014C21A and 040B21a) for COVID-19 vaccination.     Previously administered products included for Flu vaccination: Flu shot. Past adverse reactions to the above products included Vaccination complication with Flu shot. Concurrent medical conditions included Penicillin allergy.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (After the second dose, similar but much more mild, lasted for one day, body aches), FATIGUE (After the second dose, similar but much more mild, lasted for one day, Fatigue) and PYREXIA (After the second dose, similar but much more mild, lasted for one day,Fever). At the time of the report, MYALGIA (After the second dose, similar but much more mild, lasted for one day, body aches), FATIGUE (After the second dose, similar but much more mild, lasted for one day, Fatigue) and PYREXIA (After the second dose, similar but much more mild, lasted for one day,Fever) had resolved.            The patient did not have any COVID-19 test or diagnosed previously. The patient did not have any medical history relating to mentioned AE and both Acute and Chronic illnesses at the time of vaccination. No other vaccines given within 1 month prior to Moderna COVID-19 vaccine. The patient did not seek ay medical for the adverse events. Previously the patient had flu shot and experienced a similar event which was a bit more dramatic.  No concomitant and treatment medications were reported.   This case was linked to MOD-2022-543451, MOD-2022-543456, MOD-2022-543457 (Patient Link).
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Fatigue, Myalgia, Pyrexia
Clinical narrative: After the second dose, similar but much more mild, lasted for one day, body aches; After the second dose, similar but much more mild, lasted for one day, Fatigue; After the second dose, similar but much more mild, lasted for one day,Fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (After the second dose, similar but much more mild, lasted for one day, body aches), FATIGUE (After the second dose, similar but much more mild, lasted for one day, Fatigue) and PYREXIA (After the second dose, similar but much more mild, lasted for one day,Fever) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014C21A and 040B21a) for COVID-19 vaccination.     Previously administered products included for Flu vaccination: Flu shot. Past adverse reactions to the above products included Vaccination complication with Flu shot. Concurrent medical conditions included Penicillin allergy.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (After the second dose, similar but much more mild, lasted for one day, body aches), FATIGUE (After the second dose, similar but much more mild, lasted for one day, Fatigue) and PYREXIA (After the second dose, similar but much more mild, lasted for one day,Fever). At the time of the report, MYALGIA (After the second dose, similar but much more mild, lasted for one day, body aches), FATIGUE (After the second dose, similar but much more mild, lasted for one day, Fatigue) and PYREXIA (After the second dose, similar but much more mild, lasted for one day,Fever) had resolved.            The patient did not have any COVID-19 test or diagnosed previously. The patient did not have any medical history relating to mentioned AE and both Acute and Chronic illnesses at the time of vaccination. No other vaccines given within 1 month prior to Moderna COVID-19 vaccine. The patient did not seek ay medical for the adverse events. Previously the patient had flu shot and experienced a similar event which was a bit more dramatic.  No concomitant and treatment medications were reported.   This case was linked to MOD-2022-543451, MOD-2022-543456, MOD-2022-543457 (Patient Link).
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Immunisation reaction
Clinical narrative: After the second dose, similar but much more mild, lasted for one day, body aches; After the second dose, similar but much more mild, lasted for one day, Fatigue; After the second dose, similar but much more mild, lasted for one day,Fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (After the second dose, similar but much more mild, lasted for one day, body aches), FATIGUE (After the second dose, similar but much more mild, lasted for one day, Fatigue) and PYREXIA (After the second dose, similar but much more mild, lasted for one day,Fever) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014C21A and 040B21a) for COVID-19 vaccination.     Previously administered products included for Flu vaccination: Flu shot. Past adverse reactions to the above products included Vaccination complication with Flu shot. Concurrent medical conditions included Penicillin allergy.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (After the second dose, similar but much more mild, lasted for one day, body aches), FATIGUE (After the second dose, similar but much more mild, lasted for one day, Fatigue) and PYREXIA (After the second dose, similar but much more mild, lasted for one day,Fever). At the time of the report, MYALGIA (After the second dose, similar but much more mild, lasted for one day, body aches), FATIGUE (After the second dose, similar but much more mild, lasted for one day, Fatigue) and PYREXIA (After the second dose, similar but much more mild, lasted for one day,Fever) had resolved.            The patient did not have any COVID-19 test or diagnosed previously. The patient did not have any medical history relating to mentioned AE and both Acute and Chronic illnesses at the time of vaccination. No other vaccines given within 1 month prior to Moderna COVID-19 vaccine. The patient did not seek ay medical for the adverse events. Previously the patient had flu shot and experienced a similar event which was a bit more dramatic.  No concomitant and treatment medications were reported.   This case was linked to MOD-2022-543451, MOD-2022-543456, MOD-2022-543457 (Patient Link).
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Fatigue, Throat irritation
Clinical narrative: After the second dose, similar but much more mild, lasted for one day, body aches; After the second dose, similar but much more mild, lasted for one day, Fatigue; After the second dose, similar but much more mild, lasted for one day,Fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (After the second dose, similar but much more mild, lasted for one day, body aches), FATIGUE (After the second dose, similar but much more mild, lasted for one day, Fatigue) and PYREXIA (After the second dose, similar but much more mild, lasted for one day,Fever) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014C21A and 040B21a) for COVID-19 vaccination.     Previously administered products included for Flu vaccination: Flu shot. Past adverse reactions to the above products included Vaccination complication with Flu shot. Concurrent medical conditions included Penicillin allergy.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (After the second dose, similar but much more mild, lasted for one day, body aches), FATIGUE (After the second dose, similar but much more mild, lasted for one day, Fatigue) and PYREXIA (After the second dose, similar but much more mild, lasted for one day,Fever). At the time of the report, MYALGIA (After the second dose, similar but much more mild, lasted for one day, body aches), FATIGUE (After the second dose, similar but much more mild, lasted for one day, Fatigue) and PYREXIA (After the second dose, similar but much more mild, lasted for one day,Fever) had resolved.            The patient did not have any COVID-19 test or diagnosed previously. The patient did not have any medical history relating to mentioned AE and both Acute and Chronic illnesses at the time of vaccination. No other vaccines given within 1 month prior to Moderna COVID-19 vaccine. The patient did not seek ay medical for the adverse events. Previously the patient had flu shot and experienced a similar event which was a bit more dramatic.  No concomitant and treatment medications were reported.   This case was linked to MOD-2022-543451, MOD-2022-543456, MOD-2022-543457 (Patient Link).
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Fatigue, Pain, Pyrexia, Vomiting
Clinical narrative: For the first booster only had one day of symptom; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (For the first booster only had one day of symptom) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058F21A, 014C21A and 040B21a) for COVID-19 vaccination.     Previously administered products included for Flu vaccination: Flu shot. Past adverse reactions to the above products included Vaccination adverse reaction with Flu shot. Concurrent medical conditions included Penicillin allergy.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (For the first booster only had one day of symptom). At the time of the report, VACCINATION COMPLICATION (For the first booster only had one day of symptom) had resolved.            The patient never had COVID positive test or diagnosis and not had any medical history related to acute with chronic illnesses at the time of vaccination. No concomitant medications were reported. The patient had not got COVID and because of the Moderna COVID19 vaccine, everything that happened with the patient was all broadly publicized online. The agent told the patient that Moderna could not provide medical advice and referred the patient to health care professional. It was further reported that the adverse event had not caused the patient to seek medical care (office visit, urgent care, emergency room and hospitalized). No treatment medications were reported.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Fatigue, Myalgia, Pyrexia
Clinical narrative: For the first booster only had one day of symptom; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (For the first booster only had one day of symptom) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058F21A, 014C21A and 040B21a) for COVID-19 vaccination.     Previously administered products included for Flu vaccination: Flu shot. Past adverse reactions to the above products included Vaccination adverse reaction with Flu shot. Concurrent medical conditions included Penicillin allergy.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (For the first booster only had one day of symptom). At the time of the report, VACCINATION COMPLICATION (For the first booster only had one day of symptom) had resolved.            The patient never had COVID positive test or diagnosis and not had any medical history related to acute with chronic illnesses at the time of vaccination. No concomitant medications were reported. The patient had not got COVID and because of the Moderna COVID19 vaccine, everything that happened with the patient was all broadly publicized online. The agent told the patient that Moderna could not provide medical advice and referred the patient to health care professional. It was further reported that the adverse event had not caused the patient to seek medical care (office visit, urgent care, emergency room and hospitalized). No treatment medications were reported.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Immunisation reaction
Clinical narrative: For the first booster only had one day of symptom; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (For the first booster only had one day of symptom) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058F21A, 014C21A and 040B21a) for COVID-19 vaccination.     Previously administered products included for Flu vaccination: Flu shot. Past adverse reactions to the above products included Vaccination adverse reaction with Flu shot. Concurrent medical conditions included Penicillin allergy.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (For the first booster only had one day of symptom). At the time of the report, VACCINATION COMPLICATION (For the first booster only had one day of symptom) had resolved.            The patient never had COVID positive test or diagnosis and not had any medical history related to acute with chronic illnesses at the time of vaccination. No concomitant medications were reported. The patient had not got COVID and because of the Moderna COVID19 vaccine, everything that happened with the patient was all broadly publicized online. The agent told the patient that Moderna could not provide medical advice and referred the patient to health care professional. It was further reported that the adverse event had not caused the patient to seek medical care (office visit, urgent care, emergency room and hospitalized). No treatment medications were reported.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Fatigue, Throat irritation
Clinical narrative: For the first booster only had one day of symptom; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (For the first booster only had one day of symptom) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058F21A, 014C21A and 040B21a) for COVID-19 vaccination.     Previously administered products included for Flu vaccination: Flu shot. Past adverse reactions to the above products included Vaccination adverse reaction with Flu shot. Concurrent medical conditions included Penicillin allergy.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (For the first booster only had one day of symptom). At the time of the report, VACCINATION COMPLICATION (For the first booster only had one day of symptom) had resolved.            The patient never had COVID positive test or diagnosis and not had any medical history related to acute with chronic illnesses at the time of vaccination. No concomitant medications were reported. The patient had not got COVID and because of the Moderna COVID19 vaccine, everything that happened with the patient was all broadly publicized online. The agent told the patient that Moderna could not provide medical advice and referred the patient to health care professional. It was further reported that the adverse event had not caused the patient to seek medical care (office visit, urgent care, emergency room and hospitalized). No treatment medications were reported.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Fatigue, Pain, Pyrexia, Vomiting
Clinical narrative: After the second booster only have fatigue; scratchy throat; This spontaneous case was reported by a consumer and describes the occurrence of THROAT IRRITATION (scratchy throat) and FATIGUE (After the second booster only have fatigue) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 056A22A, 058F21A, 014C21A and 040B21a) for COVID-19 vaccination.     The patient had never been diagnosed with/ tested positive for COVID 19.  Acute and chronic illness at the time of vaccination and up to one month before was reported as none.  Previously administered products included for Flu vaccination: Flu Shot (Similar to the flu shot and and a bit more dramatic). Past adverse reactions to the above products included Vaccination adverse reaction with Flu Shot. Concurrent medical conditions included Penicillin allergy.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Apr-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced THROAT IRRITATION (scratchy throat). On an unknown date, the patient experienced FATIGUE (After the second booster only have fatigue). At the time of the report, THROAT IRRITATION (scratchy throat) and FATIGUE (After the second booster only have fatigue) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported.  Other vaccines given within 1 month prior to Moderna COVID-19 vaccine was reported as none. The patient had not got COVID and because of the Moderna COVID19 vaccine. The agent told the patient that Moderna could not provide medical advice and referred the patient to health care professional. It was further reported that the adverse event had not caused the patient to seek medical care (office visit, urgent care, emergency room and hospitalized). History related to mentioned AE and both acute and chronic illnesses at the time of vaccination.  Treatment information was not reported.   This case was linked to MOD-2022-543451, MOD-2022-543454, MOD-2022-543456 (Patient Link).
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Fatigue, Myalgia, Pyrexia
Clinical narrative: After the second booster only have fatigue; scratchy throat; This spontaneous case was reported by a consumer and describes the occurrence of THROAT IRRITATION (scratchy throat) and FATIGUE (After the second booster only have fatigue) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 056A22A, 058F21A, 014C21A and 040B21a) for COVID-19 vaccination.     The patient had never been diagnosed with/ tested positive for COVID 19.  Acute and chronic illness at the time of vaccination and up to one month before was reported as none.  Previously administered products included for Flu vaccination: Flu Shot (Similar to the flu shot and and a bit more dramatic). Past adverse reactions to the above products included Vaccination adverse reaction with Flu Shot. Concurrent medical conditions included Penicillin allergy.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Apr-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced THROAT IRRITATION (scratchy throat). On an unknown date, the patient experienced FATIGUE (After the second booster only have fatigue). At the time of the report, THROAT IRRITATION (scratchy throat) and FATIGUE (After the second booster only have fatigue) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported.  Other vaccines given within 1 month prior to Moderna COVID-19 vaccine was reported as none. The patient had not got COVID and because of the Moderna COVID19 vaccine. The agent told the patient that Moderna could not provide medical advice and referred the patient to health care professional. It was further reported that the adverse event had not caused the patient to seek medical care (office visit, urgent care, emergency room and hospitalized). History related to mentioned AE and both acute and chronic illnesses at the time of vaccination.  Treatment information was not reported.   This case was linked to MOD-2022-543451, MOD-2022-543454, MOD-2022-543456 (Patient Link).
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Immunisation reaction
Clinical narrative: After the second booster only have fatigue; scratchy throat; This spontaneous case was reported by a consumer and describes the occurrence of THROAT IRRITATION (scratchy throat) and FATIGUE (After the second booster only have fatigue) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 056A22A, 058F21A, 014C21A and 040B21a) for COVID-19 vaccination.     The patient had never been diagnosed with/ tested positive for COVID 19.  Acute and chronic illness at the time of vaccination and up to one month before was reported as none.  Previously administered products included for Flu vaccination: Flu Shot (Similar to the flu shot and and a bit more dramatic). Past adverse reactions to the above products included Vaccination adverse reaction with Flu Shot. Concurrent medical conditions included Penicillin allergy.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Apr-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced THROAT IRRITATION (scratchy throat). On an unknown date, the patient experienced FATIGUE (After the second booster only have fatigue). At the time of the report, THROAT IRRITATION (scratchy throat) and FATIGUE (After the second booster only have fatigue) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported.  Other vaccines given within 1 month prior to Moderna COVID-19 vaccine was reported as none. The patient had not got COVID and because of the Moderna COVID19 vaccine. The agent told the patient that Moderna could not provide medical advice and referred the patient to health care professional. It was further reported that the adverse event had not caused the patient to seek medical care (office visit, urgent care, emergency room and hospitalized). History related to mentioned AE and both acute and chronic illnesses at the time of vaccination.  Treatment information was not reported.   This case was linked to MOD-2022-543451, MOD-2022-543454, MOD-2022-543456 (Patient Link).
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Fatigue, Throat irritation
Clinical narrative: After the second booster only have fatigue; scratchy throat; This spontaneous case was reported by a consumer and describes the occurrence of THROAT IRRITATION (scratchy throat) and FATIGUE (After the second booster only have fatigue) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 056A22A, 058F21A, 014C21A and 040B21a) for COVID-19 vaccination.     The patient had never been diagnosed with/ tested positive for COVID 19.  Acute and chronic illness at the time of vaccination and up to one month before was reported as none.  Previously administered products included for Flu vaccination: Flu Shot (Similar to the flu shot and and a bit more dramatic). Past adverse reactions to the above products included Vaccination adverse reaction with Flu Shot. Concurrent medical conditions included Penicillin allergy.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Apr-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced THROAT IRRITATION (scratchy throat). On an unknown date, the patient experienced FATIGUE (After the second booster only have fatigue). At the time of the report, THROAT IRRITATION (scratchy throat) and FATIGUE (After the second booster only have fatigue) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not reported.  Other vaccines given within 1 month prior to Moderna COVID-19 vaccine was reported as none. The patient had not got COVID and because of the Moderna COVID19 vaccine. The agent told the patient that Moderna could not provide medical advice and referred the patient to health care professional. It was further reported that the adverse event had not caused the patient to seek medical care (office visit, urgent care, emergency room and hospitalized). History related to mentioned AE and both acute and chronic illnesses at the time of vaccination.  Treatment information was not reported.   This case was linked to MOD-2022-543451, MOD-2022-543454, MOD-2022-543456 (Patient Link).
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: stored in the refrigerator is 20Jan2022, experied on 16Apr2022, administered on 18Apr2022; administered with expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered with expired vaccine) and PRODUCT STORAGE ERROR (stored in the refrigerator is 20Jan2022, experied on 16Apr2022, administered on 18Apr2022) in a 63-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 007J21-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Apr-2022 at 10:25 AM, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) .5 milliliter. On 18-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered with expired vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (stored in the refrigerator is 20Jan2022, experied on 16Apr2022, administered on 18Apr2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered with expired vaccine) and PRODUCT STORAGE ERROR (stored in the refrigerator is 20Jan2022, experied on 16Apr2022, administered on 18Apr2022) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown.   For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments.   A nurse reported that they inadvertently administered an expired Moderna Covid-19 vaccine to 2 patients on 18Apr2022. Lot number 007J21-2A; expiration date per expiration date look up tool online is 16Apr2022. Initial date the vial was stored in the refrigerator is 20Jan2022. They wanted to know what to do with the 2 patients who have been administered with the vaccine. Additional information was reported as follows: Dose administered after 30-day Use By Date or after manufacturer date of expiry Lot number was 007J21-2A; 16Apr2022 The Number of doses/vials: was 2 doses It was reported that the vial was initially stored in the refrigerator on 20Jan2022 The Date of administration of vaccine was18Apr2022 The vial did not undergo any temperature excursions  It was reported that  the patients received 1st doses and neither reported any side effects   Concomitant medications were not reported.  Treatment medications were not reported.    This case was linked to MOD-2022-543432 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Bronchitis
Clinical narrative: Bronchitis; This spontaneous case was reported by a consumer and describes the occurrence of BRONCHITIS (Bronchitis) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BRONCHITIS (Bronchitis). At the time of the report, BRONCHITIS (Bronchitis) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were reported. This case was linked to MOD-2022-543451 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired dose administered to a patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose administered to a patient) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007J21-2A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose administered to a patient). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired dose administered to a patient) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. Reporter confirmed an expired dose on 16Apr2022 was administered to 1 patient on 18Apr2022.  No treatment medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2022: Follow-up received includes previous dosage of suspect
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Dispensed 28 doses of expired Moderna Covid-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dispensed 28 doses of expired Moderna Covid-19 vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 06-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dispensed 28 doses of expired Moderna Covid-19 vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dispensed 28 doses of expired Moderna Covid-19 vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. Reporter confirmed that patient reported no adverse events. No treatment details were reported.
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: dispensed 28 doses of expired Moderna Covid-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dispensed 28 doses of expired Moderna Covid-19 vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 vaccination.     Patient had no known allergy. It was reported that patient had never been diagnosed/ tested positive for COVID-19. Patient had no chronic or long-standing health conditions. Patient had no acute illness at the time of vaccination and up to one month before.     On 06-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 06-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (dispensed 28 doses of expired Moderna Covid-19 vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (dispensed 28 doses of expired Moderna Covid-19 vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided.  It was reported that patient had no adverse event from the vaccine on 6 Apr 2022.  The vial did not undergo any temperature excursions. On unknown date the vial was initially stored in the refrigerator.  No treatment medication information was provided.   This case was linked to MOD-2022-541343 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine had an expiry date on 18-Mar-2022 and patient received the vaccine on 06-Apr-2022/dispensed 28 doses of expired Moderna Covid-19 vaccine.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine had an expiry date on 18-Mar-2022 and patient received the vaccine on 06-Apr-2022/dispensed 28 doses of expired Moderna Covid-19 vaccine.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 vaccination.     Acute illnesses at the time of vaccination and up to one month before/Chronic and long standing health conditions were reported as None.     On 06-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 06-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine had an expiry date on 18-Mar-2022 and patient received the vaccine on 06-Apr-2022/dispensed 28 doses of expired Moderna Covid-19 vaccine.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine had an expiry date on 18-Mar-2022 and patient received the vaccine on 06-Apr-2022/dispensed 28 doses of expired Moderna Covid-19 vaccine.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Prescriptions, over-the-counter medications, dietary supplements, or herbal remedies being taken at time of vaccination and/or at the time of the adverse event was reported as None.  The patient had never diagnosed or tested positive for Covid-19.  The patient reports no adverse event form the vaccine on 06-Apr-2022. The vaccine had an expiration date 18-Mar-2022 and a stability study has been initiated with moderna.  .   This case was linked to MOD-2022-541343 (Patient Link).
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was given expired dose of Moderna vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was given expired dose of Moderna vaccine) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011F21A) for COVID-19 vaccination.     No known drug allergies were reported. Patient did not have acute illnesses at time of vaccination or 1 month before vaccination. Patient did not receive other vaccines within 1 month prior to Moderna COVID-19 vaccine. The patient never had adverse event following any previous vaccines.  Concurrent medical conditions included Hypertension.  On 23-Mar-2022 at 1:15 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2022 at 1:15 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was given expired dose of Moderna vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was given expired dose of Moderna vaccine) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information was provided. The vial did not undergo any temperature excursions. The patient did not experience any adverse event. No treatment medication were provided.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient received dose 1 on 11-Jan-2021 and dose 2 on 08-Feb-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received dose 1 on 11-Jan-2021 and dose 2 on 08-Feb-2022) in a 53-year-old female patient who received mRNA-1273 (Spikevax) (batch nos. 031l20a and 012L20A) for COVID-19 vaccination.     Concurrent medical conditions included Fruit allergy (Orange), Allergy to vaccine (Pneumococcal 23-valent polysaccharide vaccine), Allergy to antibiotic (Rocephin) and Seafood allergy (Shrimp).   On 11-Jan-2021 at 10:36 AM, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 08-Feb-2022 at 5:44 PM, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to .5 milliliter. On 08-Feb-2022 at 5:44 PM,  after starting mRNA-1273 (Spikevax), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received dose 1 on 11-Jan-2021 and dose 2 on 08-Feb-2022). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received dose 1 on 11-Jan-2021 and dose 2 on 08-Feb-2022) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  It was reported that patient did not experience any adverse event including signs and symptoms, clinical course or treatment with date or timelines.  No treatment medications were reported.   This case was linked to MOD-2022-504696 (Patient Link).
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered past expiration date) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011F21A) for COVID-19 vaccination. Patient didn't received other vaccines within one month prior Moderna vaccination. Patient didn't had adverse event following previous vaccination. Concurrent medical conditions included Penicillin allergy, Chronic kidney disease stage 3, Diabetes mellitus, Hypertension and Parkinson's disease. On 23-Mar-2022 at 1:00 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2022 at 1:00 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered past expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered past expiration date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No Concomitant Products were reported. Vial didn't undergo any temperature excursions. Patient didn't experience an adverse event. No Treatment information was reported.
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, SARS-CoV-2 test
Clinical narrative: This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dispensed 28 doses of expired Moderna Covid-19 vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 vaccination. No Medical History information was reported. On 08-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 08-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (dispensed 28 doses of expired Moderna Covid-19 vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (dispensed 28 doses of expired Moderna Covid-19 vaccine) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: no (Negative) No. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient had no Known Allergy. No concomitant medication were reported. No treatment drug were reported. The vial  was not underwent any temperature excursions. Vial was transferred from another store. The vaccine had an expiration date 18-Mar-2022 and a stability study has been initiated with Moderna. The patient reported that no adverse event from the vaccine. This case was linked to MOD-2022-544296 (Patient Link).